Header Logo

Connection

JOHN VIERLING to Liver Transplantation

Back to Details
This is a "connection" page, showing publications JOHN VIERLING has written about Liver Transplantation.
JOHN VIERLING
Connection Strength
2.815
Liver Transplantation
  1. Liver transplantation in autoimmune liver diseases. Best Pract Res Clin Gastroenterol. 2011 Dec; 25(6):765-82.
    View in: PubMed
    Score: 0.196
  2. Acute liver failure. Curr Opin Organ Transplant. 2011 Jun; 16(3):289-96.
    View in: PubMed
    Score: 0.189
  3. Comparison of the applicability of two prognostic scoring systems in patients with fulminant hepatic failure. Korean J Intern Med. 2007 Jun; 22(2):93-100.
    View in: PubMed
    Score: 0.143
  4. Transplantation of the right hepatic lobe. N Engl J Med. 2002 Aug 22; 347(8):615-8; author reply 615-8.
    View in: PubMed
    Score: 0.103
  5. Practical Consideration for Drug Monitoring of Tacrolimus in Liver Transplantation Recipients with SARS-CoV-2 Infection. Liver Transpl. 2022 01; 28(1):127-130.
    View in: PubMed
    Score: 0.097
  6. Donor Gamma-Glutamyl Transferase Is Associated With Liver Allograft Discard and Failure. Prog Transplant. 2021 06; 31(2):101-107.
    View in: PubMed
    Score: 0.093
  7. Presentation and Outcomes of Autoimmune Hepatitis Type 1 and Type 2 in Children: A Single-center Study. J Pediatr Gastroenterol Nutr. 2021 01 01; 72(1):101-107.
    View in: PubMed
    Score: 0.092
  8. Combined Lung-Liver and Delayed Kidney Transplantation for Cystic Fibrosis Clinical Approach and Outcome: A Case Report. Transplant Proc. 2020 Nov; 52(9):2824-2826.
    View in: PubMed
    Score: 0.088
  9. Introduction to hepatitis B transplantation. Semin Liver Dis. 2000; 20 Suppl 1:1-2.
    View in: PubMed
    Score: 0.086
  10. Case studies of the hepatitis B patient: a panel discussion. Semin Liver Dis. 2000; 20 Suppl 1:29-35.
    View in: PubMed
    Score: 0.086
  11. Immunology of acute and chronic hepatic allograft rejection. Liver Transpl Surg. 1999 Jul; 5(4 Suppl 1):S1-S20.
    View in: PubMed
    Score: 0.083
  12. The Observer Effect in Liver Transplantation Exemplified by Unintended Consequences of Regulation and Selected Outcome Metrics. Prog Transplant. 2019 09; 29(3):291-292.
    View in: PubMed
    Score: 0.082
  13. No Gains in Long-term Survival After Liver Transplantation Over the Past Three Decades. Ann Surg. 2019 01; 269(1):20-27.
    View in: PubMed
    Score: 0.080
  14. Predicting Liver Allograft Discard: The Discard Risk Index. Transplantation. 2018 09; 102(9):1520-1529.
    View in: PubMed
    Score: 0.078
  15. Cystatin C Is a Gender-Neutral Glomerular Filtration Rate Biomarker in Patients with Cirrhosis. Dig Dis Sci. 2018 03; 63(3):665-675.
    View in: PubMed
    Score: 0.075
  16. Liver transplant length of stay (LOS) index: A novel predictive score for hospital length of stay following liver transplantation. Clin Transplant. 2017 Dec; 31(12).
    View in: PubMed
    Score: 0.074
  17. A Surge in cadaveric liver donors and a national narcotic epidemic: Is there an association? Liver Transpl. 2017 05; 23(5):698-700.
    View in: PubMed
    Score: 0.071
  18. Morbidity and mortality of recurrent hepatitis C infection after orthotopic liver transplantation. J Viral Hepat. 1997; 4 Suppl 1:117-24.
    View in: PubMed
    Score: 0.070
  19. Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post-liver transplantation recurrence. Hepatology. 2016 May; 63(5):1493-505.
    View in: PubMed
    Score: 0.066
  20. Recurrence of viral hepatitis after liver transplantation: insights into management. Liver Transpl Surg. 1995 Sep; 1(5 Suppl 1):89-99.
    View in: PubMed
    Score: 0.063
  21. Autoimmune hepatitis. Front Med. 2015 Jun; 9(2):187-219.
    View in: PubMed
    Score: 0.061
  22. Acute liver failure due to lymphoma. A diagnostic concern when considering liver transplantation. Dig Dis Sci. 1994 Jun; 39(6):1351-8.
    View in: PubMed
    Score: 0.058
  23. Long-term follow-up of portopulmonary hypertension patients after liver transplantation. Liver Transpl. 2014 Jun; 20(6):724-7.
    View in: PubMed
    Score: 0.058
  24. Diagnosis and treatment of autoimmune hepatitis. Curr Gastroenterol Rep. 2012 Feb; 14(1):25-36.
    View in: PubMed
    Score: 0.050
  25. Immunologic mechanisms of hepatic allograft rejection. Semin Liver Dis. 1992 Feb; 12(1):16-27.
    View in: PubMed
    Score: 0.050
  26. Waitlist mortality decreases with increased use of extended criteria donor liver grafts at adult liver transplant centers. Am J Transplant. 2007 May; 7(5):1265-70.
    View in: PubMed
    Score: 0.035
  27. Justice, administrative law, and the transplant clinician: the ethical and legislative basis of a national policy on donor liver allocation. J Contemp Health Law Policy. 2007; 23(2):200-30.
    View in: PubMed
    Score: 0.035
  28. Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula. Liver Transpl. 2006 Dec; 12(12 Suppl 3):S128-36.
    View in: PubMed
    Score: 0.035
  29. Successful liver transplantation following medical management of portopulmonary hypertension: a single-center series. Am J Transplant. 2006 Sep; 6(9):2177-82.
    View in: PubMed
    Score: 0.034
  30. Living donor liver transplantation: histological abnormalities found on liver biopsies of apparently healthy potential donors. J Gastroenterol Hepatol. 2006 Feb; 21(2):381-3.
    View in: PubMed
    Score: 0.033
  31. Histopathology of early and late human hepatic allograft rejection: evidence of progressive destruction of interlobular bile ducts. Hepatology. 1985 Nov-Dec; 5(6):1076-82.
    View in: PubMed
    Score: 0.032
  32. Electron microscopy of rejected human liver allografts. Hepatology. 1985 Nov-Dec; 5(6):1083-7.
    View in: PubMed
    Score: 0.032
  33. Crohn's ileitis after liver transplantation from a living related donor with Crohn's disease. Gut. 2004 Sep; 53(9):1389-90.
    View in: PubMed
    Score: 0.030
  34. Epidemiology and clinical course of liver diseases: identification of candidates for hepatic transplantation. Hepatology. 1984 Jan-Feb; 4(1 Suppl):84S-94S.
    View in: PubMed
    Score: 0.028
  35. Relationship of pretransplant hepatobiliary disease to bile duct damage occurring in the liver allograft. Hepatology. 1983 Jan-Feb; 3(1):84-9.
    View in: PubMed
    Score: 0.026
  36. Retrospective analysis of the results of liver transplantation for adults with severe hepatopulmonary syndrome. Liver Transpl. 2002 Oct; 8(10):925-31.
    View in: PubMed
    Score: 0.026
  37. Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy. Liver Transpl. 2001 Jun; 7(6):513-7.
    View in: PubMed
    Score: 0.024
  38. Overview of hepatitis B and transplantation in the hepatitis B patient. Semin Liver Dis. 2000; 20 Suppl 1:3-6.
    View in: PubMed
    Score: 0.021
  39. Posttransplantation: future therapies. Semin Liver Dis. 2000; 20 Suppl 1:19-24.
    View in: PubMed
    Score: 0.021
  40. Mycotic aneurysm of arterial conduit presenting as massive upper gastrointestinal hemorrhage after liver transplantation. Liver Transpl Surg. 1998 Sep; 4(5):435-6.
    View in: PubMed
    Score: 0.020
  41. Autoimmune hepatitis. Nat Rev Dis Primers. 2018 04 12; 4:18017.
    View in: PubMed
    Score: 0.019
  42. Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis. Hepatology. 1998 Jan; 27(1):213-22.
    View in: PubMed
    Score: 0.019
  43. Comparison of histopathology in acute allograft rejection and recurrent hepatitis C infection after liver transplantation. Liver Transpl Surg. 1997 Jul; 3(4):398-406.
    View in: PubMed
    Score: 0.018
  44. Treatment of the postoperative alcoholic liver transplant recipient with other addictions. Liver Transpl Surg. 1997 May; 3(3):322-7.
    View in: PubMed
    Score: 0.018
  45. Transjugular intrahepatic portosystemic shunt: efficacy for the treatment of portal hypertension and impact on liver transplantation. Am Surg. 1996 Oct; 62(10):835-9.
    View in: PubMed
    Score: 0.017
  46. Cutting edge issues in autoimmune hepatitis. J Autoimmun. 2016 Dec; 75:6-19.
    View in: PubMed
    Score: 0.017
  47. Tacrolimus (FK 506) for rescue of chronic rejection following orthotopic liver transplantation. Transplant Proc. 1996 Apr; 28(2):1011-3.
    View in: PubMed
    Score: 0.017
  48. Portal vein patency in candidates for liver transplantation: MR angiographic analysis. Radiology. 1995 Oct; 197(1):147-52.
    View in: PubMed
    Score: 0.016
  49. Malignant vascular tumors of the liver presenting as liver failure and portal hypertension. Liver Transpl Surg. 1995 May; 1(3):156-61.
    View in: PubMed
    Score: 0.016
  50. Immune disorders of the liver and bile duct. Gastroenterol Clin North Am. 1992 Jun; 21(2):427-49.
    View in: PubMed
    Score: 0.013
  51. Disappearing bile ducts: immunologic mechanisms. Hosp Pract (Off Ed). 1990 Jul 15; 25(7):141-50.
    View in: PubMed
    Score: 0.011
  52. Morbidity in live liver donors: standards-based adverse event reporting further refined. Arch Surg. 2005 Sep; 140(9):888-95; discussion 895-6.
    View in: PubMed
    Score: 0.008
  53. Hepatitis C virus is not recoverable from liver tissue in cryptogenic cirrhosis: failure to identify hepatitis C virus-RNA using reverse transcription-mediated polymerase chain reaction. Hum Pathol. 1996 Nov; 27(11):1161-5.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.